Different effect of IgA nephropathy and polycystic kidney disease on arterial stiffness

Kidney and Blood Pressure Research

Volumn 34, Issue 3, 2011, Pages 158-166

  Késoi, István ^a,c   Sági, Balázs ^a   Tóth, Orsolya I ^a   Vas, Tibor ^a   Fazekas, Attila ^a   Kovács, Tibor ^a   Pintér, Tünde ^b   Wittmann, István ^a   Nagy, Judit ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c Komló Health Center   (Hungary)

Author keywords

Arterial stiffness; Chronic kidney disease; IgA nephropathy; Polycystic kidney disease; Renal function

Indexed keywords

GLUCOSE;

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEART RATE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RISK ASSESSMENT; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

ADULT; ARTERIES; BLOOD PRESSURE; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINGERS; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOTOPLETHYSMOGRAPHY; POLYCYSTIC KIDNEY DISEASES; REGIONAL BLOOD FLOW; RENAL CIRCULATION; RISK FACTORS;

EID: 79953693285     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000326802     Document Type: Article

References (59)

1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-S119. (Pubitemid 28527268)
2. Levin A: Cardiac disease in chronic kidney disease: current understandings and opportunities for change. Blood Purif 2004; 22: 21-27. (Pubitemid 38142285)
3. Laurent S, Cockroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B,Viachopoulos C, Wilkinson I, Struijker- Boudier H, European Network for Non-invasive Investigation of Large Arteries: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-2605. (Pubitemid 44627304)
4. Laurent S, Boutouyrie, P, Asmar R, Gautier I, Laloux B: Cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236-1241.
5. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P: Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1203-1206. (Pubitemid 36547514)
6. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002; 106: 2085-2090. (Pubitemid 35192814)
7. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J: Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664-670.
8. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
9. London GM, Marchais SJ, Guérin AP, Métivier F: Arteriosclerosis, vascular calcifications and cardiovascular disease in uraemia. Curr Opin Nephrol Hypertens 2005; 14: 525-531. (Pubitemid 41531842)
10. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992. (Pubitemid 32183805)
11. Sollinger D, Mohaupt MG, Wilhelm A, Uehlinger D, Frey FJ, Eisenberger U: Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis 2006; 48: 456-463. (Pubitemid 44247250)
12. Covic A, Gusbeth-Tatomir P, Goldsmith DJA: Arterial stiffness in renal patients: an update. Am J Kidney Dis 2005; 45: 965-977. (Pubitemid 40806509)
13. El Hadj Othmane T, Nemcsik J, Fekete BCs, Deák Gy, Egresits J, Fodor E, Logan AG, Németh ZsK, Járai Z, Szabó T, Szathmári M, Kiss I, Tislér A: Arterial stiffness in hemodialysis: which parameter to measure to predict cardiovascular mortality? Kidney Blood Press Res 2009; 32: 250-257.
14. Upadhyay A, Hwang SJ, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, Meigs JB, Larson MG, Levy D, Benjamin EJ, Fox CS: Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 2009; 20: 2044-2053.
15. Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, Froissart M, Houillier P, Boutouyrie P: Arterial stiffness and enlargement in mild-to moderate chronic kidney disease. Kidney Int 2006; 69: 350-357. (Pubitemid 43323087)
16. Wang MC, Tsai WC, Chen JY, Huang JJ: Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005; 45: 494-501.
17. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M: Aortic PWV in chronic kidney disease: a CIRC ancillary study. Am J Hypertens 2010; 23: 282-289.
18. London GM, Marchais SJ, Guerin AP, Pannier B: Arterial stiffness: pathophysiology and clinical impact. Clin Exp Hypertens 2004;26:689-699. (Pubitemid 40129757)
19. Gusbeth-Tatomir P, Covic A: Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 2007;30:97-107. (Pubitemid 46674914)
20. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727. (Pubitemid 18047151)
21. Floege J, Freehally J: IgA nephropathy: recent developments. J Am Soc Nephrol 2000; 11: 2395-2403.
22. Syrjänen J, Mustonen J, Pasternack A: Hypertrigliceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000; 15: 34-42. (Pubitemid 30037928)
23. Myllymäki J, Syrjänen J, Helin H, Pasternack A, Kattainen A, Mustonen J: Vascular diseases and their risk factors in IgA nephropathy. Nephrol Dial Transplant 2006; 21: 1876-1882. (Pubitemid 43985716)
24. Torres WE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301. (Pubitemid 46552051)
25. Ecder T, Schrier RW: Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol 2009; 5: 221-228.
26. Kocaman O, Oflaz H, Yeleker E, Dursun M, Erdogan D, Demirel S, Alisir S, Turgut F, Mercanoglu F, Ecder T: Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2004; 43: 854-860. (Pubitemid 38529623)
27. Fick GM, Johnson AM, Hammond WS, Gabow PA: Causes of death in autosomal polycystic kidney disease. J Am Soc Nephrol 1995; 5: 2046-2056.
28. Perrone RD, Ruthazer R, Terrin NC: Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis 2001; 38: 777-784.
29. Haddad N, Brown C, Hebert LA: Retarding progression of kidney disease; in Feehally J, Floege J, Johnson RJ (eds): Comprehensive Clinical Nephrology. Amsterdam, Mosby, Elsevier, 2007, pp 823-830.
30. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD): Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007; 28: 88-136.
31. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39:S1-S266.
32. Millasseau SC, Ritter JM, Takazawa K, Chowienczyk PJ: Contour analysis of the photopletysmographic pulse measured at the finger. Review. J Hypertens 2006; 24: 1449-1456. (Pubitemid 44162443)
33. Alty SR, Angarita-Jaimes N, Millasseau SC, Chowienczyk PJ: Predicting arterial stiffness from the digital volume pulse waveform. IEEE Trans Biomed Eng 2007; 54: 2268-2275. (Pubitemid 350157792)
34. Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ: Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci 2002; 103: 371-377. (Pubitemid 35193240)
35. Chowienczyk PJ, Kelly RP, MacCallum H, et al: Photopletysmographic assessment of pulse wave reflection. J Am Coll Cardiol 1999; 34: 2007-2014.
36. Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ: The vascular impact of aging and vasoactive drugs: comparison of two digital volume pulse measurements. Am J Hypertens 2003; 16: 467-472. (Pubitemid 36667801)
37. Sollinger D, Mohaupt MG, Wilhelm A, Uehlinger D, Frey FJ, Eisenberger U: Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis 2006; 48: 456-463. (Pubitemid 44247250)
38. Wang MC, Tsai WC, Chen JY, Huang JJ: Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005; 45: 494-501.
39. Briet M, Bozec E, Laurent S, Fassot C, London GM, Jacquot C, Froissart M, Houillier P, Boutouyrie P: Arterial stiffness and enlargement in mild-to moderate chronic kidney disease. Kidney Int 2006; 69: 350-357. (Pubitemid 43323087)
40. Lacy P, Carr SJ, O'Brien D, Fentum B, Williams B, Paul SK, Robinson TG: Reduced glomerular filtration rate in pre-dialysis nondiabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance. Cli Sci 2006; 110: 101-108. (Pubitemid 43059049)
41. Konings C, Dammers R, Rensma PL, Kooman JP, Hoeks A, Kornet L, Gladziwa U, Van der Sande F, Leunissen K: Arterial wall properties in patients with renal failure. Am J Kidney Dis 2002; 39: 1206-1212. (Pubitemid 34591936)
42. Borresen ML, Wang D, Strandgaard S: Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am J Nephrol 2007; 27: 240-246. (Pubitemid 47164672)
43. Griffin MD, Torres WE, Grande JP, Kumar R: Vascular expression of polycystins. J Am Soc Nephrol 1997; 8: 616-626.
44. Gabow PA, Chapman AB, Johnson AM, Tangel DJ, Duley IT, Kaehny WD, Manco-Johnson M, Schrier RW: Renal structure and hypertension in autosomal dominant polycystic kidney disease. Kidney Int 1990; 38: 1177-1180.
45. Fick GM, Duley IT, Johnson AM, Strain JD, Manco-Johnson ML, Gabow PA: The spectrum of autosomal dominant polycystic kidney disease in children. J Am Soc Nephrol 1994; 4: 1654-1660.
46. Harrap SB, Davies DL, Macnicol AM, Dominiczak AF, Fraser R, Wright AF, Watson ML, Briggs JD: Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int 1991; 40: 501-508.
47. Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P: Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease. Kidney Int 1994; 46: 1118-1123. (Pubitemid 24319951)
48. Graham RC, Lindop GBM: The anatomy of the renin-secreting cells in adult polycystic kidney disease. Kidney Int 1988; 33: 1084-1090.
49. Mahmud A, Feely J: Arterial stiffness and the renin-angiotensin- aldosterone system. J Renin Angiotensin Aldosterone Syst 2004; 5: 102-108. (Pubitemid 39406718)
50. Gusbeth-Tatomir P, Covic A: Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res 2007; 30: 97-107. (Pubitemid 46674914)
51. Nagy J, Kovács T, Wittmann I: Renal protection in IgA nephropathy requires strict blood pressure control. Nephrol Dial Transplant 2005; 20: 1533-1539. (Pubitemid 41418573)
52. van der Heijden-Spek JJ, Staessen JA, Fagard RH, Hoeks AP, Boudier HA, van Bortel LM: Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 2000; 35: 637-642. (Pubitemid 30108161)
53. Woodman RJ, Kingwell BA, Beilin LJ, Hamilton SE, Dart AM, Watts GF: Assessment of central and peripheral arterial stiffness. Am J Hypertens 2005; 18: 249-260.
54. Simonetti GD, Eisenberger U, Bergmann IP, Frey FJ, Mohaupt MG: Pulse contour analysis: a valid assessment of central arterial stiffness in children? Pediatr Nephrol 2008; 23: 439-444.
55. Hashimoto J, Watabe D, Kimura A, Takahashi H, Ohkubo T, Totsune K, Imai Y: Determinants of the second derivate of the finger photoplethysmogram and brachial-ankle pulse-wave velocity: the Okasama Study. Am J Hypertens 2005; 18: 477-485.
56. Chen JY, Tsai WC, Lin CC, Huang YY, Hsu CH, Liu PY, Chen JH: Stiffness index derived from digital volume pulse as a marker of target organ damage in untreated hypertension. Blood Press 2005; 14: 233-237.
57. Gunarathne A, Patel JV, Hughes EA, Lip GY: Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification. Am J Hypertens 2008; 21: 866-872.
58. Mackenzie IS, Wilkinson IB, Cockroft JR: Assessment of arterial stiffness in clinical practice. Q J Med 2002; 95: 67-74. (Pubitemid 34187779)
59. Padilla JM, Berjano EJ, Sáiz J, Fácila L, Díaz P, Mercé S: Assessment of relationship between blood pressure, pulse wave velocity and digital volume pulse. Comput Cardiol 2006; 33: 893-896.